ATLANTA, GA-The AP (4/16, Stobbe) reports the Advisory Committee on Immunization Practices on Wednesday “recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.” The 15-member expert panel “also voted to recommend a shot to protect travelers from a mosquito-borne illness called chikungunya.”
Reuters (4/16, S K, Sunny) reports the panel “voted 14-to-0 to recommend that at-risk adults ages 50 to 59 receive a single dose of RSV vaccine,” with one member abstaining. The CDC “currently recommends the vaccine for adults age 75 and older and at-risk adults ages 60 to 74.” If the agency adopts the recommendation, “it would make about 30% of U.S. adults in that age group eligible for the RSV vaccine, according to panelist Michael Melgar.”
Media Release/From The AMA
